Astrana Health [ASTH] vs Pediatrix Medical [MD] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Astrana Health Inc. wins in 5 metrics, Pediatrix Medical Group, Inc. wins in 15 metrics, with 0 ties. Pediatrix Medical Group, Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Astrana Health Inc. | Pediatrix Medical Group, Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 73.30 | 11.88 | Pediatrix Medical Group, Inc. |
| Price-to-Book Ratio | 2.12 | 2.16 | Astrana Health Inc. |
| Debt-to-Equity Ratio | 193.10 | 73.29 | Pediatrix Medical Group, Inc. |
| PEG Ratio | -0.41 | 9.90 | Pediatrix Medical Group, Inc. |
| EV/EBITDA | 14.57 | 7.92 | Pediatrix Medical Group, Inc. |
| Profit Margin (TTM) | 0.71% | 8.64% | Pediatrix Medical Group, Inc. |
| Operating Margin (TTM) | 1.85% | 11.07% | Pediatrix Medical Group, Inc. |
| EBITDA Margin (TTM) | 1.85% | 11.07% | Pediatrix Medical Group, Inc. |
| Return on Equity | 4.49% | 20.28% | Pediatrix Medical Group, Inc. |
| Return on Assets (TTM) | 3.43% | 6.57% | Pediatrix Medical Group, Inc. |
| Free Cash Flow (TTM) | $104.49M | $252.63M | Pediatrix Medical Group, Inc. |
| 1-Year Return | 49.98% | 73.57% | Pediatrix Medical Group, Inc. |
| Price-to-Sales Ratio (TTM) | 0.59 | 1.00 | Astrana Health Inc. |
| Enterprise Value | $2.10B | $2.00B | Astrana Health Inc. |
| EV/Revenue Ratio | 0.66 | 1.05 | Astrana Health Inc. |
| Gross Profit Margin (TTM) | 10.00% | 25.51% | Pediatrix Medical Group, Inc. |
| Revenue per Share (TTM) | $65 | $23 | Astrana Health Inc. |
| Earnings per Share (Diluted) | $0.46 | $1.94 | Pediatrix Medical Group, Inc. |
| Beta (Stock Volatility) | 0.77 | 0.72 | Pediatrix Medical Group, Inc. |
| Short % of Float | 8.35% | 6.00% | Pediatrix Medical Group, Inc. |
Astrana Health Inc. vs Pediatrix Medical Group, Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Astrana Health Inc. | -0.62% | -0.03% | 0.31% | 56.02% | 72.11% | 52.18% |
| Pediatrix Medical Group, Inc. | 0.29% | 8.46% | 8.36% | 25.04% | 7.40% | 14.47% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Astrana Health Inc. | 49.98% | 24.10% | -27.77% | 642.69% | 657.25% | 657.25% |
| Pediatrix Medical Group, Inc. | 73.57% | 75.20% | -20.69% | -64.71% | -31.34% | 9.12% |
Performance & Financial Health Analysis: Astrana Health Inc. vs Pediatrix Medical Group, Inc.
| Metric | ASTH | MD |
|---|---|---|
| Market Information | ||
| Market Cap | $1.88B | $1.91B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 497,178 | 510,889 |
| 90 Day Avg. Volume | 435,283 | 755,756 |
| Last Close | $38.38 | $24.37 |
| 52 Week Range | $18.08 - $40.13 | $11.84 - $24.99 |
| % from 52W High | -4.36% | -2.48% |
| All-Time High | $133.23 (Nov 15, 2021) | $86.09 (Aug 17, 2015) |
| % from All-Time High | -71.19% | -71.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.43% | -0.02% |
| Quarterly Earnings Growth | 0.43% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.09% |
| Operating Margin (TTM) | 0.02% | 0.11% |
| Return on Equity (TTM) | 0.04% | 0.20% |
| Debt to Equity (MRQ) | 193.10 | 73.29 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $15.94 | $10.68 |
| Cash per Share (MRQ) | $8.68 | $6.16 |
| Operating Cash Flow (TTM) | $114.60M | $271.09M |
| Levered Free Cash Flow (TTM) | $227.95M | $190.33M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Astrana Health Inc. vs Pediatrix Medical Group, Inc.
| Metric | ASTH (Apr 26, 2026) | MD (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 73.30 | 11.88 |
| Forward P/E | 10.50 | 9.90 |
| PEG Ratio | -0.41 | 9.90 |
| Price to Sales (TTM) | 0.59 | 1.00 |
| Price to Book (MRQ) | 2.12 | 2.16 |
| Market Capitalization | ||
| Market Capitalization | $1.88B | $1.91B |
| Enterprise Value | $2.10B | $2.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.66 | 1.05 |
| Enterprise to EBITDA | 14.57 | 7.92 |
| Risk & Other Metrics | ||
| Beta | 0.77 | 0.72 |
| Book Value per Share (MRQ) | $15.94 | $10.68 |
Financial Statements Comparison: Astrana Health Inc. vs Pediatrix Medical Group, Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ASTH (2025) | MD (2025) |
|---|---|---|
| Revenue/Sales | 3.18B | 1.91B |
| Cost of Goods Sold | 2.84B | 1.42B |
| COGS % of Revenue | 89.3% | 74.2% |
| Gross Profit | 341.53M | 493.70M |
| Gross Margin | 10.7% | 25.8% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 78.53M | 231.09M |
| Operating Margin | 2.5% | 12.1% |
| EBITDA | 135.35M | 256.55M |
| EBITDA Margin | 4.3% | 13.4% |
| Pre-Tax Income | 39.61M | 216.43M |
| Pre-Tax Income % of Revenue | 1.2% | 11.3% |
| Income Tax | 15.53M | 51.04M |
| Income Tax % of Revenue | 0.5% | 2.7% |
| Net Income (Profit) | 24.08M | 165.39M |
| Profit Margin | 0.8% | 8.6% |
Balance Sheet & Liquidity Metrics
| Metric | ASTH (2025) | MD (2025) |
|---|---|---|
| Cash & Equivalents | 429.47M | 375.24M |
| Total Current Assets | 863.31M | 763.51M |
| Total Current Assets % of Revenue | 27.1% | 39.9% |
| Total Current Liabilities | 615.27M | 458.91M |
| Total Current Liabilities % of Revenue | 19.3% | 24.0% |
| Long-Term Debt | 1.02B | 596.22M |
| Long-Term Debt % of Revenue | 32.1% | 31.2% |
| Total Shareholders Equity | 558.33M | 865.85M |
| Retained Earnings | 308.38M | -83.15M |
| Retained Earnings % of Revenue | 9.7% | -4.3% |
| Property, Plant & Equipment | 35.74M | 195.53M |
Cash Flow Statement Comparison
| Metric | ASTH (2025) | MD (2025) |
|---|---|---|
| Operating Cash Flow | 109.88M | 270.23M |
| Operating Cash Flow % of Revenue | 3.5% | 14.1% |
| Capital Expenditures | -10.11M | -18.46M |
| Free Cash Flow | 104.49M | 252.63M |
| FCF Margin | 3.3% | 13.2% |
| Debt Repayment | -495.29M | -20.75M |
| Common Stock Repurchase | -15.43M | -86.68M |
Short Interest & Institutional Ownership Analysis
| Metric | ASTH | MD |
|---|---|---|
| Shares Short | 2.68M | 3.53M |
| Short Ratio | 6.86 | 3.77 |
| Short % of Float | 8.35% | 6.00% |
| Shares Outstanding | 48.89M | 82.98M |
| Float Shares | 44.36M | 79.95M |
| % Held by Insiders | 20.32% | 2.31% |
| % Held by Institutions | 52.52% | 106.63% |
| % Held by Public | 27.16% | -8.94% |
Dividend Analysis & Yield Comparison: Astrana Health Inc. vs Pediatrix Medical Group, Inc.
| Metric | ASTH | MD |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |